You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

multiple PCR

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Development and Verification ofNew Coronavirus Multiplex Nucleic

Unknown status
  • COVID-19
  • New QIAstat-Dx fully automatic multiple PCR detection platform
  • Shanghai, Shanghai, China
    Huashan Hospital of Fudan University
May 13, 2020

STAT4 in Multiple Sclerosis by PCR and Flow Cytometry

Completed
  • Multiple Sclerosis
  • detection of STAT4 gene
  • Assiut, Egypt
    Assiut University Hospital
Jun 7, 2020

MSRV-Env Burden in Normal Population

Completed
  • Multiple Sclerosis
  • No study treatments administered
  • Annemasse, France
    Etablissement Français du Sang Rhône Alpes - 1 route de Taninges
Oct 19, 2020

Refractory Multiple Myeloma Trial in Cleveland (azacitidine, lenalidomide, dexamethasone)

Completed
Has Results
  • Refractory Multiple Myeloma
  • Cleveland, Ohio
  • +1 more
Oct 20, 2020

Performance Study of Targeted Sequencing Technology for VAP

Not yet recruiting
  • VAP - Ventilator Associated Pneumonia
  • tNGS
  • (no location specified)
Sep 6, 2023

MSRV-Env Burden in Patients With Multiple Sclerosis Disease

Completed
  • Multiple Sclerosis (MS)
  • +4 more
  • No study treatments administered - blood draws only
  • Bron cedex, France
  • +3 more
Oct 19, 2020

Role of Multiplex PCR in CAP

Not yet recruiting
  • Community-acquired Pneumonia
  • MultiplexPCR
  • (no location specified)
Oct 20, 2023

Breast Tumor Trial in Seoul (Minimally-invasive biopsy, wide excision)

Completed
Has Results
  • Breast Neoplasm
  • Minimally-invasive biopsy
  • wide excision
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 27, 2020

Assessment Model of PCR After NAT on Breast Cancer AI Technology

Recruiting
  • Breast Cancer
  • Neoadjuvant therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Jun 30, 2022

Breast Cancer, HER2-positive Breast Cancer Trial in Zhengzhou (Albumin paclitaxel+trastuzumab+pyrrolitinib,

Active, not recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Zhengzhou, Henan, China
    Henan cancer hospital
Jun 23, 2023

Blastocystis Hominis as Apotential Human Pathogen

Not yet recruiting
  • Blastocystis Hominis Infections
  • culture and PCR
  • (no location specified)
Apr 14, 2023

Urine DNA Testing for Bladder Cancer in China

Recruiting
  • Bladder Cancer
  • +3 more
  • Urine DNA methylation analysis
  • medical imaging and/or cystoscopy and/or pathological examination
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Dec 29, 2022

Sputum DNA Testing for Lung Cancer in China

Recruiting
  • Lung Cancer
  • +15 more
  • Diagnostic Test: Sputum DNA methylation analysis
  • chest CT or pathological examination
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medccal University
Dec 29, 2022

Early Predict Pathological Complete Response to Neoadjuvant

Recruiting
  • Breast Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Aug 8, 2022

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Sentinel Lymph Node Biopsy (SLNB)
    • +7 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jul 31, 2023

    Helicobacter Pylori Infection Trial in Shanghai (Esomeprazole, Bismuth potassium citrate, Metronidazole)

    Recruiting
    • Helicobacter Pylori Infection
    • Shanghai, Shanghai, China
    • +2 more
    Mar 16, 2022

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Sentinel Lymph Node Biopsy (SLNB)
    • +7 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Nov 2, 2023

    Locally Advanced Rectal Carcinoma Trial (Cadonilimab Injection, Short-course radiotherapy, Consolidation chemo)

    Not yet recruiting
    • Locally Advanced Rectal Carcinoma
    • Cadonilimab Injection
    • +2 more
    • (no location specified)
    Mar 19, 2023

    Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)

    Not yet recruiting
    • Respiratory Viral Infection
    • SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
    • BioFire Respiratory Panel 2.1
    • (no location specified)
    Jul 13, 2023

    NSCLC Trial in Beijing

    Recruiting
    • NSCLC
      • Beijing, China
        Yuyan Wang
      Oct 10, 2023

      Generic Testing of Antigen Tests for COVID-19 in Denmark

      Completed
      • SARS-CoV2 Infection
      • COVID-19 Testing
      • Comparison of antigen tests with RT-PCR as reference method
      • Aarhus, Denmark
      • +2 more
      Jan 24, 2022

      Checkpoint Inhibitors in Triple Negative Breast

      Recruiting
      • Triple Negative Breast Cancer
      • Whole Genome Sequencing
      • +7 more
      • Barcelona, Spain
        Vall d'Hebron Institute of Oncology
      Jun 20, 2023

      Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Minimal Residual Disease
        • Chapel Hill, North Carolina
          North Carolina Cancer Hospital (NCCH)
        Feb 2, 2023

        Next Generation Sequencing Detection of Lyme Disease

        Completed
        • Lyme Disease
        • +5 more
          • Setauket, New York
            Clinical Research Center
          Feb 23, 2022

          Cytomegalovirus Anterior Uveitis Trial in San Francisco (Valganciclovir Hydrochloride, Ganciclovir Sodium, Placebo Oral Tablet)

          Recruiting
          • Cytomegalovirus Anterior Uveitis
          • Valganciclovir Hydrochloride
          • +3 more
          • San Francisco, California
            Proctor Foundation, UCSF
          Jul 1, 2022